跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion - UK EMC Drug Approval Details
Approvals
/
UK EMC
/
Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion
Approved
STANDARD
Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion
Ranbaxy (UK) Limited a Sun Pharmaceutical Company
🇬🇧 Electronic Medicines Compendium
Approval Date
N/A
Approval ID
5d088600a50d6d00
Company
Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Type
Standard
Approval Details
Approval Id
5d088600a50d6d00
Drug Approval Emc Name
Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion
Drug Name
Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion
Company Name
Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Company Address
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
Company Website
http://www.sunpharma.com
Company Telephone
+44 (0) 208 848 8688
Company Medical Info Direct Line
+44 (0) 208 848 5052
Company Medical Info Email
medinfoeurope@sunpharma.com
Atc Code
L01DB01
Legal Category
Prescription only medicine
Active Ingredients
Approved
Quick Info
Agency
UK EMC
Country
🇬🇧
Approval ID
5d088600a50d6d00
Type
Standard
Back to UK EMC Approvals